PROCEPT BioRobotics Corp (PRCT): Price and Financial Metrics

PROCEPT BioRobotics Corp (PRCT): $50.71

2.61 (-4.89%)

POWR Rating

Component Grades








PRCT Price/Volume Stats

Current price $50.71 52-week high $54.50
Prev. close $53.32 52-week low $24.83
Day low $50.37 Volume 419,507
Day high $52.92 Avg. volume 488,842
50-day MA $48.83 Dividend yield N/A
200-day MA $38.96 Market Cap 2.58B

PRCT Stock Price Chart Interactive Chart >

PROCEPT BioRobotics Corp (PRCT) Company Bio

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is based in Redwood City, California.

PRCT Latest News Stream

Event/Time News Detail
Loading, please wait...

PRCT Latest Social Stream

Loading social stream, please wait...

View Full PRCT Social Stream

Latest PRCT News From Around the Web

Below are the latest news stories about PROCEPT BIOROBOTICS CORP that investors may wish to consider to help them evaluate PRCT as an investment opportunity.

Insider Sell Alert: EVP Alaleh Nouri Divests 15,000 Shares of PROCEPT BioRobotics Corp

In a notable insider transaction, Alaleh Nouri, the Executive Vice President, Chief Legal Officer, and Corporate Secretary of PROCEPT BioRobotics Corp, sold 15,000 shares of the company on December 15, 2023.

Yahoo | December 16, 2023

Insider Sell Alert: Director Frederic Moll Sells 79,000 Shares of PROCEPT BioRobotics Corp (PRCT)

In a notable insider transaction, Director Frederic Moll has parted with a significant number of shares in PROCEPT BioRobotics Corp (NASDAQ:PRCT).

Yahoo | December 10, 2023

EVP, CFO Kevin Waters Sells 15,085 Shares of PROCEPT BioRobotics Corp (PRCT)

Kevin Waters, the Executive Vice President and Chief Financial Officer of PROCEPT BioRobotics Corp, has recently sold a significant number of shares in the company.

Yahoo | December 9, 2023

PROCEPT BioRobotics Stock Scores Rising Relative Strength

PROCEPT BioRobotics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Yahoo | December 5, 2023

Investors Appear Satisfied With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Prospects As Shares Rocket 32%

PROCEPT BioRobotics Corporation ( NASDAQ:PRCT ) shares have had a really impressive month, gaining 32% after a shaky...

Yahoo | November 24, 2023

Read More 'PRCT' Stories Here

PRCT Price Returns

1-mo 1.06%
3-mo 8.31%
6-mo 88.23%
1-year 40.01%
3-year N/A
5-year N/A
YTD 21.00%
2023 0.89%
2022 66.09%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!